StonvexLoading…
StonvexStonvexStonvexCore line items from CLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.77B | $3.10B | $1.43B | $7.10B |
Operating Income | $578.00M | $322.00M | $107.00M | $1.08B |
Net Income | $424.00M | $237.00M | $80.00M | $810.00M |
EPS (Diluted) | $3.47 | $1.93 | $0.65 | $6.52 |
Total Assets | $6.44B | $5.61B | $5.53B | $5.56B |
Total Liabilities | $6.34B | $5.58B | $5.39B | $5.08B |
Cash & Equivalents | $1.19B | $227.00M | $166.00M | $167.00M |
Free Cash Flow OCF − CapEx | $161.00M | $326.00M | $57.00M | $761.00M |
Shares Outstanding | 120.92M | 120.89M | 121.78M | 122.69M |